問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

蔡佳宏
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

4Cases

2025-07-01 - 2029-02-12

Phase II

Active
A Phase II, Randomized, Open-label, Multi-center Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
  • Condition/Disease

    Metastatic Hormone-sensitive Prostate Cancer

  • Test Drug

    Tablets

Participate Sites
2Sites

Recruiting2Sites

2022-05-20 - 2026-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Recruiting3Sites

2025-09-15 - 2036-04-30

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Recruiting3Sites

2025-08-01 - 2032-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites